Effect of recombinant human erythropoietin and its combination with tamoxifen on viability of MCF-7 cell in three-dimensional culture
Anemia is often a side-effect of cancers. Erythropoietin (EPO) is the erythropoiesisstimulating hormone produced by the kidneys that is used in the treatment of anemias. This hormone is being used concurrently with chemotherapeutic drugs in the treatment of cancers. From previous studies, EPO alo...
Saved in:
| 主要作者: | |
|---|---|
| 格式: | Thesis |
| 語言: | English |
| 出版: |
2019
|
| 主題: | |
| 在線閱讀: | http://psasir.upm.edu.my/id/eprint/99228/1/IB%202021%203%20IR.pdf |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|